Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

MAFbx/Atrogin-1 is required for atrophic remodeling of the unloaded heart

Baskin, KK and Rodriguez, MR and Kansara, S and Chen, W and Carranza, S and Frazier, OH and Glass, DJ and Taegtmeyer, H (2014) MAFbx/Atrogin-1 is required for atrophic remodeling of the unloaded heart. Journal of Molecular and Cellular Cardiology. pp. 168-176.

Abstract

BACKGROUND: Mechanical unloading of the failing human heart induces profound cardiac changes resulting in the reversal of a distorted structure and function. In this process, cardiomyocytes break down unneeded proteins and replace those with new ones. The specificity of protein degradation via the ubiquitin proteasome system is regulated by ubiquitin ligases. Over-expressing the ubiquitin ligase MAFbx/Atrogin-1 in the heart inhibits the development of cardiac hypertrophy, but the role of MAFbx/Atrogin-1 in the unloaded heart is not known. METHODS AND RESULTS: Mechanical unloading, by heterotopic transplantation, decreased heart weight and cardiomyocyte cross-sectional area in wild type mouse hearts. Unexpectedly, MAFbx/Atrogin-1-/- hearts hypertrophied after transplantation (n=8-10). Proteasome activity and markers of autophagy were increased to the same extent in WT and MAFbx/Atrogin-1-/- hearts after transplantation (unloading). Calcineurin, a regulator of cardiac hypertrophy, was only upregulated in MAFbx/Atrogin-1-/- transplanted hearts, while the mTOR pathway was similarly activated in unloaded WT and MAFbx/Atrogin-1-/- hearts. MAFbx/Atrogin-1-/- cardiomyocytes exhibited increased calcineurin protein expression, NFAT transcriptional activity, and protein synthesis rates, while inhibition of calcineurin normalized NFAT activity and protein synthesis. Lastly, mechanical unloading of failing human hearts with a left ventricular assist device (n=18) also increased MAFbx/Atrogin-1 protein levels and expression of NFAT regulated genes. CONCLUSIONS: MAFbx/Atrogin-1 is required for atrophic remodeling of the heart. During unloading, MAFbx/Atrogin-1 represses calcineurin-induced cardiac hypertrophy. Therefore, MAFbx/Atrogin-1 not only regulates protein degradation, but also reduces protein synthesis, exerting a dual role in regulating cardiac mass

Item Type: Article
Additional Information: NIBR author: Glass, DJ institute: NIBR contributor address: Department of Internal Medicine, Division of Cardiology, The University of Texas Health Science Center, Houston, TX, USADepartment of Internal Medicine, Division of Cardiology, The University of Texas Health Science Center, Houston, TX, USADepartment of Internal Medicine, Division of Cardiology, The University of Texas Health Science Center, Houston, TX, USADepartment of Endocrinology, Baylor College of Medicine, Houston, TX, USATexas Heart Institute, Houston, TX, USATexas Heart Institute, Houston, TX, USADepartment of Muscle Diseases, Novartis Institute for Biomedical Research, Cambridge, MA, USADepartment of Internal Medicine, Division of Cardiology, The University of Texas Health Science Center, Houston, TX, USA; Texas Heart Institute, Houston, TX, USA. Electronic address: Heinrich.Taegtmeyer@uth.tmc.edu
Date Deposited: 13 Oct 2015 13:12
Last Modified: 13 Oct 2015 13:12
URI: https://oak.novartis.com/id/eprint/22637

Search

Email Alerts

Register with OAK to receive email alerts for saved searches.